Product

Vaccination against Hepatitis A and B

1 clinical trial

4 indications

Indication
Cystic Fibrosis
Indication
Hepatitis A
Indication
Hepatitis B
Indication
Tuberculosis
Clinical trial
Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively
Status: Withdrawn, Estimated PCD: 2023-12-01